Eicosanoids & Vascular Pharmacology

Human vascular tissue research
Welcome to our homepage, enjoy your visit!

This website is certified by Health On the Net Foundation. Click to verify.

Host laboratory for BA, Master and PhD Thesis, contact: xnorel@hotmail.com,  INSERM U1148, Laboratory for Vascular Translational Science (LVTS). CHU X. Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18, France. Access, map. Tel: 33 1 40 25 75 29, Fax: 33 1 40 25 86 02.
We comply with the HONcode standard for trustworthy health information: verify here. Webmasters: X. Norel (PhD) & N. Foudi (PhD). © 2010-2013 Eicosanoids & Vasc. Pharmacol. about the website
Last update: 10/11/14



Introduction

Eicosanoids are metabolites of arachidonic acid derived from the action of the cyclooxygenase (cyclooxygenase pathway) or lypoxygenase enzymatic pathways. These metabolites may control the smooth muscle tone, the cell proliferation and migration in human vascular bed. Most of our present studies concern the 8 different prostanoid receptor subtypes (DP, EP1-4, FP, IP, TP) activated by prostaglandins and/or thromboxane and the enzymatic activities ( COX-1, COX-2, mPGES...) involved in the cyclooxygenase pathway. The roles of prostanoids in the human vascular wall are investigated in physiological and pathophysiological conditions (pulmonary hypertension, systemic hypertension, varicosity, atherosclerosis, aneurysm, preeclamsia).

--------------------------------------------------------------------

LAST PUBLICATIONS of the RESEARCH GROUP:


Decreased PGE2 Content Reduces MMP-1 Activity and Consequently Increases Collagen Density in Human Varicose Vein. 
PLoS One. 2014, Feb 5;9(2)
The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fatty Acids. 2013 Aug; 89(2-3):55-63.

The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013 Apr 1;187(7):703-14. doi: 10.1164/rccm.201208-1361OC.

Absence of inflammatory conditions in human varicose saphenous veins. Inflamm Res. 2013 Mar;62(3):299-308. doi: 10.1007/s00011-012-0578-8.